Clinical Outcomes of a Double-Blind Study of Etanercept and Methotrexate, Alone and Combined, in Patiens with Active Rheumatoid Arthritis (TEMPO Trial), Year 2 Results.

Abstract

Etanercept, Methotrexate, Rheumatoid Arthritis